Corneal Cross-linking (CXL)
This new outpatient treatment is currently the only treatment that can stop keratoconus from progressing. CXL stabilizes the cornea, helps preserve vision and may prevent a corneal transplant. To perform this procedure, an ophthalmologist first removes the outer layer of cells from your cornea. Next, vitamin B12 (riboflavin) drops are placed in your eye. The ophthalmologist then shines UV light on your eye. This activates the riboflavin and stiffens the cornea. Patients wear a protective contact lens during the five to seven day recovery period.
Bascom Palmer Eye Institute contributed to the study that lead to the approval of the treatment in the United States, and is one of the first centers to offer the treatment to patients in the United States. Following treatment, patients will need continued and close monitoring of the cornea to ensure maximum CXL benefits and no occurrence of adverse reactions.
Why Choose Bascom Palmer Eye Institute?
America’s Best Eye Care Provider. When you choose Bascom Palmer, you’re choosing the nation’s Number One eye care provider, according to U.S. News & World Report.
Comprehensive Care for a Variety of Eye Conditions. Our eye care professionals represent every ophthalmic sub-specialty, ensuring a collaborative, comprehensive approach to care. Whether your condition is common or complex with underlying causes, our all-inclusive care addresses every need.
University-based Medicine. Bascom Palmer physician-researchers are leading the way to promising new treatments for corneal and external eye conditions. Our corneal specialists lecture around the world, sharing their expertise to advance understanding of corneal conditions.
Exceptional Technology. With the region’s most advanced imaging technologies, Bascom Palmer provides fast, accurate diagnosis and precise treatments.